Table 1.
Category | Subcategory | Cases | lncRNA‐AK002107 expression | P‐value | |
---|---|---|---|---|---|
Low (n = 39) | High (n = 61) | ||||
Gender | Male | 94 | 35 | 59 | 0.152 |
Female | 6 | 4 | 2 | ||
Age (years) | ≤ 50 | 50 | 16 | 34 | 0.151 |
< 50 | 50 | 23 | 27 | ||
HBsAg | Positive | 92 | 36 | 56 | 0.928 |
Negative | 8 | 3 | 5 | ||
Child‐Pugh stage | A | 63 | 25 | 38 | < 0.001** |
B | 32 | 10 | 22 | ||
C | 5 | 4 | 1 | ||
Preoperative tumor therapy | Yes | 44 | 16 | 28 | 0.632 |
No | 56 | 23 | 33 | ||
AFP (ng·mL−1) | ≤ 400 | 60 | 31 | 29 | 0.001** |
> 400 | 40 | 8 | 32 | ||
Size of largest tumor (cm) | ≤ 5 | 52 | 28 | 24 | < 0.001** |
5–8 | 19 | 4 | 15 | ||
> 8 | 29 | 7 | 22 | ||
Tumor number | ≤ 3 | 80 | 30 | 50 | 0.539 |
> 3 | 20 | 9 | 11 | ||
Edmonson grading | I–II | 70 | 30 | 40 | 0.227 |
III–IV | 30 | 9 | 21 | ||
Macrovascular invasion | Yes | 25 | 1 | 24 | < 0.001** |
No | 75 | 38 | 37 | ||
Microvascular invasion | Yes | 19 | 3 | 16 | |
No | 81 | 35 | 46 | 0.027* |
* P < 0.05; ** P 0.01.